Research collaboration agreement with Allergan (Details) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
|
Jul. 24, 2015
USD ($)
Option
|
Dec. 31, 2018
USD ($)
|
Dec. 31, 2017
USD ($)
|
|
| Research collaboration and development services agreements with Allergan | |||
| Collaboration and grant revenue | $ 6,574 | $ 4,962 | |
| Research and development | 48,788 | 31,644 | |
| RCA | |||
| Research collaboration and development services agreements with Allergan | |||
| Amount to be received for each option exercised | $ 1,000 | ||
| Number of options to acquire molecules | Option | 3 | ||
| Collaboration and grant revenue | 1,000 | ||
| Research and development | $ 7,900 | $ 7,900 | |
| Development activities reimbursement percentage | 50.00% | 50.00% | |
| Development activities expenses reimbursed | $ 3,900 | $ 3,900 | |